期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肠促胰素胰腺外获益之心血管保护 被引量：2

原文传递
导出
摘要 2014年美国糖尿病学会（ADA）年会上,Banting奖获得者是肠促胰素研究领域的奠基人之一、加拿大多伦多大学的德鲁克教授（Daniel Drucker）,他的获奖演说“解码肠道代谢信息,推动治疗革新”再次把糖尿病领域的目光聚焦在肠促胰素上.心血管疾病是2型糖尿病的主要并发症,在血糖良好控制基础上,全面改善心血管危险因素,降低心血管疾病发病率和病死率是2型糖尿病治疗的主要目标.胰高糖素样肽1受体激动剂（GLP-1RA）和二肽基肽酶Ⅳ（DPP-4）抑制剂丰富了糖尿病治疗手段[1],而基于肠促胰素治疗的胰腺外作用也越来越受到关注,基础和临床研究帮助我们认识基于肠促胰素治疗的心血管保护作用.
作者 陈莉明
机构地区 天津医科大学代谢病医院
出处 《中华糖尿病杂志》 CAS CSCD 2014年第11期781-784,共4页 CHINESE JOURNAL OF DIABETES MELLITUS
关键词 心血管保护作用 肠道 美国糖尿病学会 心血管危险因素 2型糖尿病 腺外 二肽基肽酶Ⅳ 胰高糖素样肽
分类号 R587.2 [医药卫生—内分泌]
  • 相关文献

参考文献2

二级参考文献112

  • 1Stephens JW. The incretin system in the management of type 2 diabetes mellitus. Clin Med,2010, 10:491-495.
  • 2Hoist J J, Gromada J. Role of inreretin hormone in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol Endocrinol Metab ,2004,287 : E199-206.
  • 3Tornehave D, Kristensen P, Rcmer J, et al. Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J Histochem Cytochem,2008,56 : 841-851.
  • 4Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology, 2007,132:2131-2157.
  • 5Orskov C, Poulsen SS. Glucagon like peptide-1-(7-36)-amide receptors only in islets of Langerhans. Diabetes, 1991,40: 1292- 1296.
  • 6Holz GG, Leech CA, Heller RS, et al. cAMP-dependent mobilization of intracellular Ca^2 + stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca^2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1- (7-37). J Biol Chem, 1999,274 : 14147-14156.
  • 7Peffetti R, Merkel P. Glucagon-like peptide-1 : a major regulator of pancreatic beta-cell function. Eur J Endocrinol, 2000, 143 : 717- 775.
  • 8Drucker DJ. Glocagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis. Endocrinology, 2003,144 : 5145 -5148.
  • 9Leech CA, Holz GC, Chepurny O, et al. Expression of cAMP- regulated guanine nucleotide exchange factors in pancreatic β- cells. Bioehem Biophys Res Commun,2000, 278:44-47.
  • 10Liu J, Yin F, Xiao H, et al. Glucagon-like peptide 1 receptor plays an essential role in geniposide attenuating lipotoxicity- induced β-cell apoptosis. Toxicol In Vitro, 2012,26 : 1093-1097.

共引文献74

同被引文献35

  • 1吴焕淦,陈汉平.从经络腧穴神经科学角度探讨心与小肠相表里[J].辽宁中医杂志,1995,22(8):346-348. 被引量：11
  • 2周美启,周逸平,汪克明,胡玲,王月兰,陈业农.电针心经、小肠经对心肌缺血损伤大鼠心电图和心肌酶学的影响[J].中医药临床杂志,2005,17(6):572-573. 被引量：17
  • 3周美启,周逸平,汪克明,胡玲,王月兰,陈业农.针刺小肠经干预急性心肌缺血大鼠心脏基因表达谱研究[J].中国中医急症,2006,15(5):513-515. 被引量：12
  • 4Gutzwiller JP, Drewe J, G:ke B, S,et al. Glucagon-likepeptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2[J]. Am J Physiol, 1999, 276 (5 Pt 2):R1541-1544.
  • 5Polakof S, Miguez JM, Soengas JL. Evidence for a gut-brain axis used by glucagon-like peptide-1 to elicit hyperglycaemia in fish[J]. J Neuroendocrinol, 2011, 23 (6):508-518.
  • 6Ding X, Saxena NK, Lin S, et al.Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice[J]. Hepatology, 2006, 43(1): 173-181.
  • 7Lockie SH, Stefanidis A, Oldfield BJ, et al. Brown adipose tissue thermogenesis in the resistance to and reversal of obesity: a potential new mechanism contributing to the metabolic benefits of proglucagon-derived peptides[J]. Adipocyte, 2013, 2(4): 196-200.
  • 8Giorgino F, Laviola L, Leonardini A, et al.GLP-1: a new approach for type 2 diabetes therapy[J]. Diabetes Res Clin Pract, 2006, 74(2):S152-S155.
  • 9Thorens B, Porret A, Biihler L,et al. Cloning and functional expression of the human islet GLP- 1 receptor: demonstration that exendin-4 is an agonist and exendin-(9 - 39) an antagonist of the receptor[J]. Diabete, 1993(11), 42:1678-1682.
  • 10Lee J, Hong SW, Chae SW, et al.Exendin-4 improves steatohepatitis by increasing Sirt 1 expression in high-fat diet- induced obese C57BL/6J mice[J]. PLoS One, 2012, 7(2): 17.

引证文献2

二级引证文献10

中华糖尿病杂志
2014年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部